Senior hire to cement 2023 growth plans at Reacta Healthcare

Reacta Healthcare has appointed a new quality control manager to further expand and develop its...

My time at MEDICA 2022

By Dr Martin Wickham, Chief Commercial Officer, Reacta Healthcare   Last month I had the...

Development Bank of Wales ramping up tech equity deals since the lockdown

The Development Bank of Wales has invested £2.4m of equity into ten of Wales’ most...

Reacta Healthcare secures first US patent

Reacta Healthcare, based in Deeside North Wales, has secured its first US patent, expanding patents...

Praetura Ventures leads £2.9m investment in food allergy diagnostic firm

Praetura Ventures, the Manchester-based VC firm, has led a £2.9m funding round to support a...

UK Food Allergy Diagnostic company, Reacta Biotech, achieves MHRA Pharma GMP accreditation

Pursuant to a capital raise in 2020, Reacta has achieved its goal of securing an...

Reacta Biotech making progress on peanut diagnostic product

Deeside-based Reacta Biotech is on course to secure a market authorisation for its peanut diagnostic...

Reacta Healthcare Awarded Major Biomedical Catalyst Grant to develop Paediatric Food allergy diagnostics

The £1 million grant will support the development of the first Oral Food Challenges (OFCs)...

UK food allergy diagnostic company, Reacta Biotech raises £1.25m to continue expansion plans

We share relevant third party stories on our website. This release was written and issued...